Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04002440 · ClinicalTrials.gov registry record · NA

Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight

A NA study of Safety Issues and Efficacy, sponsored by University of California, San Diego.

Active
Registry status
NA
Development phase
28
Enrollment target
2
Study locations

NCT04002440 is a NA study of Safety Issues and Efficacy that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 28 participants, below the 118-participant average among 13 other Safety Issues trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04002440, a NA study of Safety Issues and Efficacy, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
28 participants
Enrollment target
2
Study locations

Study Summary

Among ambulatory peritoneal dialysis patients, does use of the Baxter AMIA peritoneal dialysis cycler with SHARESOURCE connectivity platform achieve dry weight targets better than use of the Baxter Home Choice Pro cycler.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT AMIA with SHARESOURCE Connectivity Platform
  • DEVICE HomeChoice PRO

Study Locations (2)

California

  • Home Dialysis Therapies of San Diego - Chula Vista
  • Home Dialysis Therapies of San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2018-11-08
Est. Completion 2022-04
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT04002440

The ClinicalTrials.gov registry entry for NCT04002440 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 118-participant average among 13 other Safety Issues trials with a reported enrollment target (76% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Safety Issues appearing as the primary indexed condition, and to 2 interventions - of which AMIA with SHARESOURCE Connectivity Platform is the first listed.

NCT04002440 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04002440 about?

NCT04002440 is a clinical study titled "Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight". Among ambulatory peritoneal dialysis patients, does use of the Baxter AMIA peritoneal dialysis cycler with SHARESOURCE connectivity platform achieve dry weight targets better than use of the Baxter Home Choice Pro cycler.

What is the current status of trial NCT04002440?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2018-11-08. Estimated completion is 2022-04.

What conditions does trial NCT04002440 study?

This clinical trial studies the following conditions: Safety Issues, Efficacy.

What interventions are being tested in trial NCT04002440?

The interventions under investigation include: AMIA with SHARESOURCE Connectivity Platform (COMBINATION_PRODUCT), HomeChoice PRO (DEVICE).

Who is sponsoring clinical trial NCT04002440?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04002440 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Safety Issues

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.